Proteolytic antibodies activate factor IX in patients with acquired hemophilia.

Constant domain-regulated antibody catalysis. J Biol Chem (2012) 0.84

Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder. J Immunol Res (2014) 0.84

Autoantibodies with enzymatic properties in human autoimmune diseases. J Autoimmun (2011) 0.82

Physiological IgM class catalytic antibodies selective for transthyretin amyloid. J Biol Chem (2014) 0.81

Need for a paradigm shift in therapeutic approaches to CNS injury. Expert Rev Neurother (2012) 0.80

IVIg treatment reduces catalytic antibody titers of renal transplanted patients. PLoS One (2013) 0.79

Two-faced catalytic autoantibodies. Blood (2011) 0.78

Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection. J Biol Chem (2012) 0.78

Biochemical features of a catalytic antibody light chain, 22F6, prepared from human lymphocytes. J Biol Chem (2013) 0.75

A monoclonal antibody to Cryptococcus neoformans glucuronoxylomannan manifests hydrolytic activity for both peptides and polysaccharides. J Biol Chem (2016) 0.75

Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients. J Immunol (2016) 0.75

Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature (2009) 3.07

Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection. AIDS (2003) 2.98

Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol (2012) 2.70

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol (2004) 2.56

NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol (2004) 2.38

Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Blood (2009) 2.33

Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med (2003) 1.95

Ethics and observational studies in medical research: various rules in a common framework. Int J Epidemiol (2009) 1.85

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood (2007) 1.83

Anticoagulant and antithrombotic properties of platelet protease nexin-1. Blood (2009) 1.62

The prevalence of proteolytic antibodies against factor VIII in hemophilia A. N Engl J Med (2002) 1.62

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol (2007) 1.57

Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity. Arterioscler Thromb Vasc Biol (2011) 1.56

Transition towards antigen-binding promiscuity of a monospecific antibody. Mol Immunol (2006) 1.54

Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B-associated thrombocytopenia. Blood (2013) 1.51

A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens. Blood (2011) 1.51

Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol (2003) 1.49

Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells. Blood (2013) 1.48

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood (2002) 1.46

Multicenter evaluation of a bilayer polymer blood collection tube for coagulation testing: effect on routine hemostasis test results and on plasma levels of coagulation activation markers. Blood Coagul Fibrinolysis (2006) 1.39

Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant. Blood (2013) 1.36

Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol (2008) 1.35

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A. Blood (2005) 1.33

Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood (2004) 1.30

Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. Am J Pathol (2009) 1.30

Metrics: journal's impact factor skewed by a single paper. Nature (2010) 1.29

Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc Natl Acad Sci U S A (2005) 1.28

Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J Immunol (2003) 1.25

PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. J Immunol (2010) 1.25

Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. J Allergy Clin Immunol (2011) 1.24

Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci U S A (2004) 1.24

P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. Blood (2006) 1.24

Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol (2012) 1.23

Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action. Nat Clin Pract Rheumatol (2007) 1.23

Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis. BMC Infect Dis (2008) 1.22

Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J Immunol (2008) 1.21

Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responses. J Biol Chem (2010) 1.20

VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors. Blood (2006) 1.20

Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol (2007) 1.18

Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome. Blood (2013) 1.17

Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants. Trends Pharmacol Sci (2009) 1.16

Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer. Int J Cancer (2013) 1.15

Journals: Open-access boom in developing nations. Nature (2013) 1.15

Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (2005) 1.15

Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era? Trends Pharmacol Sci (2004) 1.13

Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus. FASEB J (2009) 1.12

Dual role of CpG-stimulated B cells in the regulation of dendritic cells: comment on the article by Berggren et al. Arthritis Rheum (2013) 1.10

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer. Oncoimmunology (2012) 1.09

Human basophils lack the capacity to drive memory CD4⁺ T cells toward the IL-22 response. J Allergy Clin Immunol (2013) 1.09

Members of protein O-mannosyltransferase family in Aspergillus fumigatus differentially affect growth, morphogenesis and viability. Mol Microbiol (2010) 1.09

Long-term follow-up of hypothenar hammer syndrome: a series of 47 patients. Medicine (Baltimore) (2007) 1.09

Intravenous immunoglobulin-mediated regulation of Notch ligands on human dendritic cells. J Allergy Clin Immunol (2013) 1.07

Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. Cardiovasc Res (2010) 1.07

Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum (2011) 1.06

Small intestinal bacterial overgrowth in systemic sclerosis. Rheumatology (Oxford) (2009) 1.05

Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A. Blood (2008) 1.05

Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa. Blood (2008) 1.05

Interferon-α inhibition by intravenous immunoglobulin is independent of modulation of the plasmacytoid dendritic cell population in the circulation: comment on the article by Wiedeman et al. Arthritis Rheumatol (2014) 1.05

Reduced maternal mortality in Tunisia and voluntary commitment to gender-related concerns. Int J Gynaecol Obstet (2011) 1.04

Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS (2009) 1.03

Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies. Transfus Apher Sci (2007) 1.01

Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res (2009) 1.01

The antiinflammatory IgG. N Engl J Med (2008) 1.00

Immunomodulation by intravenous immunoglobulin: role of regulatory T cells. J Clin Immunol (2010) 1.00

Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B. Blood (2010) 0.99

High levels of catalytic antibodies correlate with favorable outcome in sepsis. Proc Natl Acad Sci U S A (2005) 0.99

Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G. J Biol Chem (2005) 0.98

Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease. J Rheumatol (2012) 0.98

Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol (2005) 0.98

Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination. Drug Discov Today (2011) 0.97

Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer. BMC Cancer (2008) 0.97

Antibodies use heme as a cofactor to extend their pathogen elimination activity and to acquire new effector functions. J Biol Chem (2007) 0.97

Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients. Medicine (Baltimore) (2009) 0.96

Role of natural antibodies in immune homeostasis: IVIg perspective. Autoimmun Rev (2008) 0.96

Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies. J Autoimmun (2010) 0.95

Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum (2005) 0.95

Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis. FEBS J (2010) 0.95

Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun Rev (2010) 0.95

DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells. Proc Natl Acad Sci U S A (2009) 0.94

Role of the alpha-helix 163-170 in factor Xa catalytic activity. J Biol Chem (2007) 0.94